News
News Center
2019-10-25
Jiuzhitang Maker proudly earns the title of National High-Tech Enterprise.
High-tech enterprises are a specialized qualification system established by the national government to support and encourage the growth of high-tech companies, restructure industrial sectors, and enhance the nation's economic competitiveness—playing a critically important strategic role in China's economic development.
+
2019-08-26
Stroke Forum: Who Will Achieve the First Breakthrough in Stem Cell Therapy for Stroke?
For 20 consecutive years, stroke has been the leading cause of death and disability among Chinese residents. Today, the incidence of stroke continues to rise, with an alarming trend toward younger ages at onset. May the light of regenerative medicine shine brightly on the lives of China's 12.42 million stroke survivors living with long-term disabilities—we’re committed to making this vision a reality!
+
2019-05-30
Great news! Jiuzhitang Maker joins the Chinese Society for Cell Biology.
In May 2019, Jiuzhitang Maker (Beijing) Cell Technology Co. officially joined the Chinese Society for Cell Biology as a corporate member. This move will provide Meike with an even stronger platform for academic exchange and collaboration in stem cell research, opening up more opportunities in the process.
+
2019-02-25
Jiuzhitang Maker Receives the "Zhongguancun High-Tech Enterprise" Certificate
Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. has officially been awarded the "Zhongguancun High-Tech Enterprise" certificate after successfully passing the review by the Zhongguancun Science Park Administrative Committee.
+
2018-11-05
On November 5, 2018, the Daxing District Development and Reform Commission and the Biomedical Base Committee delivered "Comprehensive Service Packages" to ten key high-tech enterprises in the park, offering them concierge-style support. Among these companies was Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
+
2018-09-15
Jiuzhitang's stem-cell drug R&D and production base is expected to be operational by 2019.
Source: China.org.cn September 17 (Reporter Du Ding) – Jiuzhitang is making a strategic move into the research, clinical development, and industrialization of stem cell therapies. Recently, Jiuzhitang’s newly established Jiuzhitang Yonghe Qihang Fund signed an investment agreement with U.S.-based Stemedica Cell Technologies Inc. Through this collaboration, Jiuzhitang will introduce cutting-edge stem cell production technologies and a robust manufacturing platform, aiming to build a commercial-grade stem cell production facility meeting both U.S. and EU cGMP standards within 3 to 5 years at the Beijing Daxing Biomedical Industry Base. Li Zhenguo, Chairman of Jiuzhitang, emphasized that the intrinsic value of traditional Chinese medicine remains largely untapped. He expressed the company’s ambition to leverage its strong position in the Chinese pharmaceutical industry as it ventures into the promising field of stem cell technology.
+
2018-09-14
In September 2018, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. signed a "Joint Construction Agreement for a Stem Cell Clinical Research Base" with Beijing Tiantan Hospital, Affiliated to Capital Medical University.
+
2018-07-17
On July 17, 2018, the R&D and production base of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd., located in Daxing District, Beijing, successfully passed the environmental protection inspection conducted by the Daxing District Environmental Protection Bureau, signaling its readiness for future research and development as well as the production of stem-cell-based pharmaceuticals.
+
2018-05-21
On May 21, 2018, Li Zhenguo, Chairman of Jiuzhi堂 Co., Ltd., along with Vice President Liu Guochao, and Zhang Quancheng, Chairman, and Gao Yansong, CEO of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd., visited the Kazakhstan National Scientific Medical Center and CITIC Group’s Astana Medical Clinic, where they finalized the basic framework for future collaboration.
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy